Amy Rylance, director of health services, equity and improvement at Prostate Cancer UK, said: “It’s wonderful news that thousands of men in England will now have access to this revolutionary targeted radiotherapy.
“It means men will go from needing 20 hospital trips in quick succession to just five, massively reducing the burden that cancer places on them and their loved ones.
“As the UK’s biggest public funder of prostate cancer research, we’re proud to have played a part in proving this treatment is safe and effective. We’re now investing further to see whether even more men could benefit, including those whose cancer has begun to spread beyond the prostate.
“This would completely shift the paradigm in prostate cancer treatment, allowing us to cure cancers that would today be described as incurable.”
Contact details are available to account holders.
Create a free account to get in touch with this expert.